Thema
Journal Article
34
Research Support, Non-U.S. Gov't
11
EC 2.7.10.1
5
Prognosis
5
Receptor, ErbB-2
5
camrelizumab
5
triple-negative breast cancer
5
73096E137E
4
Antibodies, Monoclonal, Humanized
4
Breast cancer
4
Breast neoplasms
4
CDK4/6 inhibitors
4
Clinical Trial, Phase I
4
Inflammation
4
P88XT4IS4D
4
Paclitaxel
4
Pulmonary arterial hypertension
4
Red blood cell distribution width
4
Survival
4
Systemic sclerosis
4
immunotherapy
4
Biomarkers
3
Circulating tumour DNA
3
Drug resistance
3
Lung
3
Metastatic breast cancer
3
Multicenter Study
3
Neoplasm metastasis
3
S6K1
3
cancer
3
metastatic breast cancer
3
targeted therapy
3
15H5577CQD
2
1605-68-1
2
615
2
Antineoplastic Agents, Immunological
2
C12Q: Measuring or testing processes involving enzymes, nucleic acids or microorganisms (immunoassay g01n0033530000); compositions or test papers therefor; processes of preparing such compositions; condition-responsive control in microbiological or enzymological processes
2
COVID-19
2
Capecitabine
2
Circulating Tumor DNA
2
Clinical Trial, Phase II
2
Cyclin-Dependent Kinase 4
2
Cyclin-Dependent Kinase 6
2
Docetaxel
2
EC 2.7.11.22
2
Esophageal squamous cell carcinoma
2
G01N: Investigating or analysing materials by determining their chemical or physical properties (measuring or testing processes other than immunoassay, involving enzymes or microorganisms c12m, c12q)
2
Immune Checkpoint Inhibitors
2
Letter
2
Protein Kinase Inhibitors
2
mehr ...